Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-alpha
about
Targeted therapies and the treatment of non-clear cell renal cell carcinomaMolecular Connections between Cancer Cell Metabolism and the Tumor MicroenvironmentImmunotherapy for metastatic renal cell carcinoma.Renal cell carcinoma.Assessment of efficacy, safety and quality of life of 55 patients with metastatic renal cell carcinoma treated with temsirolimus: a single-center experience in Japan.Assessment of efficacy, safety and quality of life of 110 patients treated with sunitinib as first-line therapy for metastatic renal cell carcinoma: experience in real-world clinical practice in Japan.Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments.Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions.Quality of life in patients with metastatic renal cell carcinoma: assessment of long-term survivors.Beyond traditional outcomes: improving quality of life in patients with renal cell carcinoma.Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma.Quality of life and supportive care for patients with metastatic renal cell carcinoma.Temsirolimus: a safety and efficacy review.Systematic review and meta-analysis of target terapies for the treatment of metastatic renal cancer.Pathology, therapy and prognosis of papillary renal carcinoma.Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy.Assessment of health-related quality of life in Japanese patients with metastatic renal cell carcinoma during treatment with tyrosine kinase inhibitors.
P2860
Q26995391-E5B86B5F-E417-48F7-A94D-E044C0367419Q28081657-6BD242EA-A1DF-4F14-8379-D0D0EDB1E6B5Q30234458-B68E8064-1393-472A-AC27-CB9D5199918FQ30235364-C9195F5D-82D8-4060-91B7-D3BD1B25A24CQ33410223-915F7A5E-98B0-44D6-9619-9A09108B958BQ33415035-08289AB0-B5A5-4722-A52E-5951DD3EA586Q33712944-6FA0219A-A0D2-4704-B4D2-8D6C6B7A6F79Q34206531-8AE670FF-02BA-41FF-8843-DA8674A656B5Q36625333-345BCD48-0128-4B48-970E-9BE2758ED9F9Q37403763-1D2914A3-80B7-4C24-BFC8-120830AA1FB3Q37838448-E54C9BDE-F746-4CD8-BE12-F8FB39E7E0B6Q38017587-81BDBE17-D0B3-4754-B9AF-356FA8A84032Q38031941-E6895000-0C04-4946-8963-D07414D8DB95Q38181242-8967AAA0-B1A3-4D32-89FD-06B6A5D9BCE0Q38312048-9850E563-1FCE-4F79-ADC1-A5BA20326457Q38741054-F7C905A6-DE64-4E21-9E6A-0203AE707C00Q39265746-393CDC01-0C08-4905-94E6-708EF9EFB2A9Q48067491-CBA4710B-D5F2-44AF-819D-5B2135AF4BD9
P2860
Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-alpha
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Quality of life in patients wi ...... msirolimus or interferon-alpha
@ast
Quality of life in patients wi ...... msirolimus or interferon-alpha
@en
type
label
Quality of life in patients wi ...... msirolimus or interferon-alpha
@ast
Quality of life in patients wi ...... msirolimus or interferon-alpha
@en
prefLabel
Quality of life in patients wi ...... msirolimus or interferon-alpha
@ast
Quality of life in patients wi ...... msirolimus or interferon-alpha
@en
P2093
P2860
P356
P1476
Quality of life in patients wi ...... msirolimus or interferon-alpha
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605647
P407
P577
2010-05-01T00:00:00Z
P5875
P6179
1020834282